Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO
August 10, 2021 07:00 ET
|
Recro Pharma, Inc.
EXTON, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Recro Reports Second Quarter 2021 Financial Results
August 09, 2021 16:05 ET
|
Recro Pharma, Inc.
Q2 2021 Highlighted by Revenues of $18.0 Million, an Increase of 16% Compared to Q2 2020 Revenue Multiple New Business Agreements Continue to Expand and Diversify Customer Base and Pipeline Company...
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
August 05, 2021 12:00 ET
|
AGC Biologics
Seattle, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of...
RiteDose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability
August 03, 2021 07:03 ET
|
The RiteDose Corporation
Columbia, SC, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The RiteDose Corporation, the company born from the inventors of Blow-Fill-Seal (BFS) technology, has implemented engineering innovations that will...
Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021
August 02, 2021 16:05 ET
|
Recro Pharma, Inc.
EXTON, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Global $136 Billion Active Pharmaceutical Ingredients CDMO Market to 2026 - Patent Expirations and Rise in Demand for Generic Drugs and Biologic Innovation
July 29, 2021 09:23 ET
|
Research and Markets
Dublin, July 29, 2021 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report by Product (Highly Potent API, Antibody Drug Conjugate), by...
Recro Appoints Erica Raether as Vice President of People, Culture and ESG
July 20, 2021 07:00 ET
|
Recro Pharma, Inc.
EXTON, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Pharmaceutical Contract Manufacturing Industry M&A Implications and Outlook Report 2021: Objectives, M&A Activity 2018-2020, Target Characteristics, Acquirer Characteristics, Geography, Top Acquirers
July 16, 2021 07:48 ET
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition" report has been...
Global Pharmaceutical Contract Manufacturing Market Report 2021: Market to Reach $130.2 Billion by 2026 - API/Bulk Drugs Segments is Projected to Account for $81.5 Billion
July 15, 2021 07:23 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...